NCT02542410View on ClinicalTrials.gov

Dopamine Receptor Agonist Therapy for Pain Relief in Women Suffering From Endometriosis: A Pilot Study

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

September 30, 2018

Study Completion Date

September 30, 2018

Conditions

Endometriosis

Interventions

DRUG

Cabergoline

DRUG

Norethindrone acetate

Trial Locations (1)

02115

Children's Hospital Boston, Boston

All Listed Sponsors

lead

Boston Children's Hospital

OTHER

NCT02542410 - Dopamine Receptor Agonist Therapy for Pain Relief in Women Suffering From Endometriosis: A Pilot Study | Biotech Hunter | Biotech Hunter